Background: Reducing unnecessary laboratory blood testing in the hospital setting rep-
| BACKG ROU N D
Avoiding inappropriate laboratory blood testing in hospitalised patients represents a significant concern for the improvement of the quality and adequacy of provided healthcare. 1, 2 The spectrum of laboratory testing overuse in the hospital setting concerns both, the initial patient evaluation and scheduled checks during the follow-up. 3 The repetition of untargeted laboratory testing during the hospital stay in clinically stable patients represents an example of low-value care which potentially can harm patients. 4 Ordering laboratory testing at regular intervals (eg, daily) or on a routine basis, could in fact lead to further unnecessary diagnostic and therapeutic procedures potentially producing stress and side-effects. 1, 5 Furthermore, the interpretation of laboratory testing results without considering the pre-test probability of a disease limits the predictive value of the lab test itself, leading to an increase in false positive results and to incorrect diagnoses. [6] [7] [8] More than 50% of lab tests ordered by physicians are actually prescribed in a context of low pre-test probability or, paradoxically to reassure patients. 9 It is also known that teaching hospitals routinely order more laboratory tests for inpatients compared with non-teaching hospitals. [10] [11] [12] However, recent evidence demonstrates that advanced clinicians may be even less comfortable with limiting laboratory testing than attending physicians and residents. 13 Last but not least, it is also known that nurses including nurse practitioners may also influence the lab test ordering process.
14 Diagnostic phlebotomies are among the predictors of haemoglobin level during hospitalisation, leading, when excessive, to hospitalacquired anaemia, and potentially to increased length of hospital stay and need for blood transfusions. [15] [16] [17] In this regard, it has been estimated that 20% of in-hospital patients develops moderate to severe anaemia, with the haemoglobin dropping from normal to <11 g/dL. 18 Furthermore local pain and haematomatas are often associated with repeated blood withdrawals, both potentially producing psychological consequences on patients.
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Coming back to the opportunity of limiting unnecessary laboratory prescriptions, growing evidence suggests that decreasing the amount of laboratory tests is not associated with an increase in readmission, missed diagnoses or mortality. 20, 21 These data should reassure clinicians of the safety of reducing, in a structured way, non clinically oriented laboratory testing.
Several interventions have been targeted at the inadequacy of blood testing in hospitals. The most successful were those that implemented multifaceted approaches involving a combination of 3 strategies: education, audit, and feedback on provider ordering practices, and restrictive ordering options in the electronic prescription tools. 4, [21] [22] [23] In the context of the Choosing Wisely Campaign, an initiative launched by the American Board of Internal Medicine aimed to target unnecessary low value investigations and treatment and to promote conversation between patients and providers, several medical societies have recommended against routine laboratory testing in hospitalised patients. [24] [25] [26] The Swiss Society of General Internal Medicine, under the name of Smarter Medicine/Choosing Wisely Switzerland, joined the Campaign in 2014 and published twice a list of five high-risk interventions to be avoided in the ambulatory and hospital care setting, respectively.
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In one of these recommendations the Swiss Society of General
Internal Medicine invited physicians to avoid ordering blood tests at regular intervals or to perform routine extensive lab panels without specific clinical questions. 27 The same year, a project aimed at improving the adherence to the recommendation in a network of southern Switzerland public teaching hospitals (Ente Ospedaliero Cantonale, EOC), was launched.
In this study, we explored accordingly the efficacy of a multilevel strategy (educational plus audit and feedback plus web-based open continuous benchmarking), addressed to all healthcare providers of the internal medicine wards, aimed to reduce unnecessary inpatient laboratory testing.
The first objective of the study was to demonstrate a reduction in the number of blood withdrawals per patients following the implementation of the intervention. Secondary objectives were to demonstrate a reduction in both blood volume withdrawn and related laboratory costs. What's known
| ME THODS
• Reducing unnecessary laboratory testing in hospitalised patients is a difficult task and represents a challenge to improve the adequacy of healthcare.
• The "Choosing Wisely Campaign" is engaged in avoiding unnecessary and low value investigations. However, "do not to do" recommendations alone did not prove to be effective in influencing clinicians' prescribing (or prescription?) behaviour.
What's new
• Ιn this before and after proof of concept study, we explored a novel multimodal approach to curb laboratory testing overuse in the hospital setting.
• We found that a web-based transparent monitoring- 
| Study variables
The primary measure of interest was the number of blood withdraw- 
| Multi-level strategy
The Multi-Level Strategy was based on three key elements:
• Web-based open unmasked continuous benchmarking.
• Educational intervention (ie, meetings, feedback).
• Inclusion of all healthcare providers of the teaching hospital network (resident physicians, senior physicians, registered nurses, attending nurses). During the educational meetings 3 key messages were emphasized:
Web
• Repetitive testing has potential side effects (eg, patient discomfort, local pain, hematomas, hospital-acquired anaemia, cascade of further inappropriate tests, costs).
• 
| Data analysis
Data were analysed using the R studio software (Version 0.99.467). Partial autocorrelation function was examined to determine whether a specific adjustment was required. Serial autocorrelation
in the regression models was tested using the R's GLS function from the NLME package in the fitted segmented regression.
For the time series regression equation we also calculated: the β0 coefficient, which estimates the level of lab test prescriptions, blood volume and costs at the beginning of the observation; the β1 coefficient, which estimates the baseline trend before the intervention; the β2 coefficient, which estimates the change in lab test prescriptions, blood volume and cost level during the intervention, and the β3 coefficient, which represents the change in the slope of the trend of lab test prescriptions, blood volume and costs after the start of the intervention. In all models the 95% relative confidence intervals and associated P-values were also shown.
The statistical significance for all outcomes was set at P-value <0.05.
| RE SULTS

| Demographic and clinical characteristics of the study population
The demographic and clinical characteristics of the study population over the 3 years of the monitoring-intervention period are presented in Table 1 . A total of 33 309 admissions were analyzed (22 198 patients). The median age was 76 years (Q1-Q3, Regression Analysis of laboratory test prescriptions is shown in Table 2A .
63-84). Genders were similarly represented (females 50%
)
TA B L E 1 Characteristics of the study population for the period 2015-2017
Internal medicine departments
| Time-trend analysis of the blood volume
Before the intervention an upward trend in the monthly volume of lab prescriptions per patient was found: 0.0151 (SE 0.104 P = 0.156).
After the implementation of the intervention a significant change in trend was shown: -0.254 (SE 0.115; P = 0.035) (Figure 2A) . By
December 2017, 12 months after the start of the intervention, we estimated that the monthly average of blood volume per day of hospitalisation was 7% less than that would have been expected if the intervention had not taken place. After the intervention, the blood volume per day of hospitalisation, also showed a significant decreasing trend: -0.025 (SE 0.008; P = 0.003) ( Figure 2B ). By December Table 2B .
| Time-trend analysis of laboratory costs
After the intervention, a significant decrease in direct lab costs was found. A change in trend was observed for the lab costs per patient with a slope of -8.128 (SE 2.620; P = 0.004), which represents 17% of relative reduction ( Figure 3A) . A significant reduction in daily trend costs was also found: -0.581 (SE 0.267; P = 0.037), which represents 7% of relative reduction ( Figure 3 B; Table 2C ).
| D ISCUSS I ON
Redundant and unnecessary laboratory tests have been considered to result in an undesired cascade of further diagnostic procedures, over-diagnosis and avoidable costs worldwide. 29, 30 The Choosing Wisely Campaign engages physicians and patients in identifying and avoiding unnecessary and low value investigations and treatments.
In our Hospital Network, we have been using Choosing Wisely as a springboard for the development of initiatives aimed to optimise the adequacy of healthcare acting specifically on health care
waste. 31, 32 The implementation of a centralised web-based system, accessible to every health care provider involved in the care of the hospitalised patients, delivering unmasked data, called "Reporting and volume of blood withdrawals per patient (primary and secondary outcome, respectively). We feel that, beyond educational interventions, the peer pressure generated by the continuous open benchmarking played a determinant role in the success of our strategy. 33 The direct laboratory costs showed a significant growth reduction (secondary outcome); we have however to acknowledge that we have only stopped the growing in the request of tests and that we are probably still far away from a reasonable baseline.
Our intervention has to be seen as a proof of concept study; the computer-based reporting system could in fact be further developed. Integrating it with an educational capillary approach delivering targeted messages to users could further increase the impact of the continuous benchmarking process. The fact that attempts in reducing laboratory testing are more efficient using multifaceted approaches especially if integrated education, process changes, feedback on costs, and financial incentive are involved, was established in previous studies. 34, 35 However, most of them have focused on reducing the use of a limited number of laboratory tests. 36, 37 Our results highlight how a web-based unmasked open monitoring-benchmarking system exposing individual health care providers to peers, coupled with educational interventions, may produce a significant effect on the prescription of a variety of laboratory tests. Last but not least, we highlight the favourable cost-effectiveness of our intervention at the department level.
The costs incurred in terms of training and learning working hours and those related to the implementation of the IT system would only need about 2 years of laboratory costs saved to be counterbalanced. The computer platform implemented was however designed and used to monitor not only laboratory tests but also medications (benzodiazepines, proton pump inhibitors, neuroleptics, opioids, and corticosteroids), 31, 32 allowing for further potential cost reductions and a more favourable cost effectiveness balance. We have however to acknowledge that at the institutional level the effective laboratory cost savings (related to reagents, single use materials, and wear of laboratory equipment) were only about 20% of the amount billed to the wards as the personnel costs and part of the operating costs were not reduced.
This means that, at the institutional level, only long lasting reductions in laboratory test consumption can translate into significant cost and personnel savings.
Some further limitations of our study have to be mentioned.
Firstly, we did not provide a randomised design; therefore, we cannot demonstrate causation between the implementation of the web-based continuous survey and the outcomes. Secondly, we cannot estimate whether the reduction in blood withdrawals observed translates into better health outcomes (ie, reduction of hospital induced anaemia, in blood withdrawals related pain and in in-hospital anxiety).
In conclusion, our pilot study showed that an open web-based system, involving all health care providers, coupled with educational interventions, could be a helpful tool to generate awareness of prescriber habits and to catalyse changes in their behaviour. The peer pressure related to the unmasked benchmarking process probably played a determinant role. Thanks to the proposed approach, the number of laboratory tests, the blood volume withdrawn and the related costs were reduced in a significant as well as sustained way.
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